Inventor · disambiguated record
Jean Merrill
Also filed as: MERRILL JEAN · MERRILL JEAN E
6 granted patents·9 pending applications·6 citations·filing 2003–2009
72Inventor score
Top patents by PatentIndex Score
15 records- 0176US7638539B21, 3, 4-oxadiazol-2-ones as peroxisome-proliferator activated receptor delta modulators and their use in the treatment of neurological and metabolic diseaseAVENTIS PHARMA INC·Filed 2006·Granted Dec 29, 2009·2 cites·2 claims
- 0266US7872032B21, 3, 4-oxadiazol-2-ones as PPAR delta modulators and their use thereofAVENTIS PARMACEUTICALS INC·Filed 2009·Granted Jan 18, 2011·1 cites·4 claims
- 0358US7709509B2Oxadiazolones and derivatives thereof as peroxisome proliferator-activated receptor (PPAR) delta agonistsSANOFI AVENTIS DEUTSCHLAND·Filed 2008·Granted May 4, 2010·0 cites·32 claims
- 0458US7132428B2Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disordersAVENTIS PHARMA INC·Filed 2003·Granted Nov 7, 2006·2 cites·5 claims
- 0557US7538233B2Coumarins as iNOS inhibitorsAVENTIS PHARMA INC·Filed 2004·Granted May 26, 2009·1 cites·7 claims
- 0651US2007179191A1Oxadiazolones and derivatives thereof as ppar delta agonistsSANOFI AVENTIS DEUTSCHLAND·Filed 2006·Application pending·0 cites
- 0750US2007249706A1Use of certain biphenyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms)AVENTIS PHARMA INC·Filed 2007·Application pending·0 cites
- 0846US2004033226A1Osteopontin, oligodendrocytes and myelinationAVENTIS PHARMA INC·Filed 2003·Application pending·0 cites
- 0945US7576109B21,3,4-oxadiazol-2-ones as PPAR delta modulators and their use thereofAVENTIS PHARMA INC·Filed 2006·Granted Aug 18, 2009·0 cites·15 claims
- 1041US2007128667A1Secreted neural apoptosis inhibiting proteinsAVENTIS PHARMA INC·Filed 2004·Application pending·0 cites
- 1140US2007149580A1Use of peroxisome proliferator activated receptor delta agonists for the treatment of ms and other demyelinating diseasesAVENTIS PHARMA INC·Filed 2006·Application pending·0 cites
- 1239US2007249732A1Use of certain phenyl napthyl compounds for protection of neurons and oligodendrocytes in the treatment of multiple sclerosis (ms)AVENTIS PHARMA INC·Filed 2007·Application pending·0 cites
- 1338US2007280885A1Methods Of Treating Demyelinating DisordersAVENTIS PHARMA INC·Filed 2005·Application pending·0 cites
- 1437US2007225330A1Use of certain phenyl-naphthyl compounds that do not have significant affinity to er alpha or er beta for protection of neurons and oligodendrocytes in the treatment of multiple sclerosisAVENTIS PHARMA INC·Filed 2007·Application pending·0 cites
- 1537US2008033005A1Methods for the treatment of multiple sclerosisAVENTIS PHARMA INC·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jean Merrill files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →